GSDME showed a higher expression in IGHV unmutated CLL than in IGHV mutated CLL (p = 0.035), while no difference was found in NLRP3 and PLCG1 (Figure 8A). This evidence concerns the gene PLCG1 and B-cell chronic lymphocytic leukemia.